Suppr超能文献

日本肺癌中大型肿瘤抑制基因的高甲基化

Hypermethylation of the large tumor suppressor genes in Japanese lung cancer.

作者信息

Sasaki Hidefumi, Hikosaka Yu, Kawano Osamu, Yano Motoki, Fujii Yoshitaka

机构信息

Department of Oncology, Immunology and Surgery, Nagoya City University Medical School, Nagoya 467-8601, Japan.

出版信息

Oncol Lett. 2010 Mar;1(2):303-307. doi: 10.3892/ol_00000054. Epub 2010 Mar 1.

Abstract

Large tumor suppressor (LATS) 1 and 2 are tumor suppressor genes implicated in the regulation of the cell cycle. The methylation statuses of the promoter regions of these genes were studied in Japanese lung cancers. The methylation statuses of the promoter regions of LATS1 and LATS2 were investigated by methylation-specific PCR. The findings were compared to clinicopathological features of lung cancer. Methylation-specific PCR showed that the LATS1 promoter region was hypermethylated in 95 out of 119 (79.8%) lung cancers. The methylation status of LATS1 was significantly associated with squamous histology (p=0.0267) and smoking status (never smoker vs. smoker; p=0.0399). LATS1-ummethylated patients harbored more EGFR mutations (p=0.0143). The LATS2 promoter region was hypermethylated in 160 out of 203 (78.8%) lung cancers. However, the methylation status had no association with the clinicopathological characteristics of the lung cancers cases. Both the LATS1 and LATS2 methylation statuses did not correlate with survival of lung cancer patients. Thus, the EGFR methylation status of the LATS genes has limited value in Japanese lung cancers.

摘要

大肿瘤抑制因子(LATS)1和2是参与细胞周期调控的肿瘤抑制基因。在日本肺癌患者中研究了这些基因启动子区域的甲基化状态。采用甲基化特异性PCR检测LATS1和LATS2启动子区域的甲基化状态,并将结果与肺癌的临床病理特征进行比较。甲基化特异性PCR结果显示,119例肺癌中有95例(79.8%)LATS1启动子区域发生高甲基化。LATS1的甲基化状态与鳞状组织学(p=0.0267)和吸烟状态(从不吸烟者与吸烟者;p=0.0399)显著相关。LATS1未甲基化的患者携带更多的表皮生长因子受体(EGFR)突变(p=0.0143)。203例肺癌中有160例(78.8%)LATS2启动子区域发生高甲基化。然而,甲基化状态与肺癌病例的临床病理特征无关。LATS1和LATS2的甲基化状态均与肺癌患者的生存率无关。因此,LATS基因的EGFR甲基化状态在日本肺癌中的价值有限。

相似文献

引用本文的文献

4
The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.LATS1 和 LATS2 肿瘤抑制因子:超越 Hippo 通路。
Cell Death Differ. 2017 Sep;24(9):1488-1501. doi: 10.1038/cdd.2017.99. Epub 2017 Jun 23.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验